Medplus Health Services Limited
Medplus Health Services board meeting rescheduled to May 20, 2026, from its original date of May 29. The meeting will consider the audited yearly standalone and consolidated financial results for FY26, among other business.
May 03 2026 14:05:00
Medplus Health Services Ltd - 543427 - Update on board meeting
Medplus Health's Board meeting has been rescheduled to May 20, 2026. The board will consider and approve the audited standalone and consolidated financial results for Q4 FY26 and the full financial year ended March 31, 2026.
May 03 2026 14:05:00
Medplus Health Services Limited
MedPlus Health Services Limited's Board of Directors is scheduled to meet on May 20, 2026. The primary agenda is to consider and approve the audited Standalone and Consolidated Financial Results for the quarter and financial year ending March 31, 2026.
May 03 2026 14:05:00
Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
MedPlus Health Services received two Stay Orders from authorities in Pune, Maharashtra, against a previous suspension. This development follows the company's submissions on Feb 04 and Mar 04, 2026, indicating a positive resolution to a regulatory issue.
Apr 28 2026 16:04:00
Medplus Health Services Limited
MedPlus Health Services Limited received two Stay Orders against a suspension from Pune, Maharashtra authorities. These orders follow earlier submissions on February 4 and March 4, 2026.
Apr 28 2026 16:04:00
Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Optival Health Solutions, a subsidiary of MedPlus Health Services, received a five-day drug license suspension for a store in Jayanagar, Karnataka, starting April 21, 2026. This regulatory action, initiated by the Drugs Control Administration, may result in a potential revenue loss of ₹5.39 lacs for the company.
Apr 22 2026 18:04:00
Medplus Health Services Limited
MedPlus Health subsidiary Optival Health Solutions received a 5-day drug license suspension for a store in Jayanagar, Karnataka. This regulatory action carries a potential revenue loss of ₹5.39 lacs for the company. The order was issued by the Assistant Director, Drugs Control Administration, Bangalore.
Apr 22 2026 17:04:00
Medplus Health Services Limited
MedPlus Health Services subsidiary Optival Health Solutions received two drug license suspension orders, impacting two stores. These suspensions are due to violations of the Drugs and Cosmetics Act, 1940, and Rules, 1945, resulting in a potential revenue loss of ₹1.25 lakhs.
Apr 20 2026 18:04:00
Medplus Health Services Limited
MedPlus subsidiary Optival Health Solutions received two drug license suspension orders in Karnataka. The suspensions, for 4 and 5 days, could lead to a total revenue loss of ₹4.98 lakhs.
Apr 17 2026 17:04:00
Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
MedPlus Health's subsidiary Optival Health Solutions received two drug license suspension orders, leading to a potential revenue loss of ₹6.81 lacs. The orders were issued by drug control authorities in Andhra Pradesh and Odisha for rule violations.
Apr 15 2026 17:04:00
Read More